V028-3605 Screening compound: 1-[3-(4-chlorophenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-4-[(thiophen-3-yl)methyl]piperazine

V028-3605 Screening compound: 1-[3-(4-chlorophenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-4-[(thiophen-3-yl)methyl]piperazine
V028-3605 Screening compound: 1-[3-(4-chlorophenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-4-[(thiophen-3-yl)methyl]piperazine alternative view

Chemical Structure Depiction of ChemDiv screening compound V028-3605
1-[3-(4-chlorophenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-4-[(thiophen-3-yl)methyl]piperazine

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

V028-3605

Molecular Formula

C24H21ClN6S (C24 H21 ClN6 S)

Compound Name

1-[3-(4-chlorophenyl)-[1,2,4]triazolo[4,3-c]quinazolin-5-yl]-4-[(thiophen-3-yl)methyl]piperazine

IUPAC name

1-[3-(4-chlorophenyl)-[124]triazolo[43-c]quinazolin-5-yl]-4-[(thiophen-3-yl)methyl]piperazine

SMILES

Clc(cc1)ccc1-c1nnc2n1c(N1CCN(Cc3cscc3)CC1)nc1c2cccc1

InChI

InChI=1S/C24H21ClN6S/c25-19-7-5-18(6-8-19)22-27-28-23-20-3-1-2-4-21(20)26-24(31(22)23)30-12-10-29(11-13-30)15-17-9-14-32-16-17/h1-9,14,16H,10-13,15H2

InChI Key

QFPDYBMBPWWHIQ-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD19902533

Chemical and Physical Properties

Saltdata

not_available

Molecular Weight

460.99

Hydrogen Bond Acceptors Count

4.00

Hydrogen Bond Donors Count

0.00

Rotatable Bond Count

4.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

5.140

Distribution Coefficient, logD

4.407

Water Solubility, LogSw

-5.97

Polar Surface Area

37.552

Acid Dissociation Constant (pKa)

20.55

Base Dissociation Constant (pKb)

8.04

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

20.80

V028-3605 in Drug Discovery

Included in Screening Libraries

Angiogenesis library (14822 compounds)

Neurotransmitter Transporter Inhibitors Library (11024 compounds)

Adenosine Receptors Targeted Library (19896 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Cancer
  • Digestive system
  • Respiratory tract
  • Nervous system
  • Eye
  • Cardiovascular
Targets:
  • GPCR
  • Ion Channels
  • GPCR
Mechanism of action:
  • Receptor's ligands

References: we are preparing a list of scientific research reports with V028-3605 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound V028-3605?
Check Price and Availability of V028-3605, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of V028-3605 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for V028-3605
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for V028-3605
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of V028-3605 available by request